Shayne & Jacobs LLC Reduces Position in HCA Healthcare, Inc. $HCA

Shayne & Jacobs LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 91,561 shares of the company’s stock after selling 4,000 shares during the quarter. HCA Healthcare accounts for approximately 11.6% of Shayne & Jacobs LLC’s investment portfolio, making the stock its 2nd biggest holding. Shayne & Jacobs LLC’s holdings in HCA Healthcare were worth $35,077,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. ORG Partners LLC lifted its position in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after acquiring an additional 31 shares in the last quarter. Avantax Advisory Services Inc. lifted its position in shares of HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after buying an additional 32 shares in the last quarter. Glenview Trust co lifted its position in shares of HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after buying an additional 32 shares in the last quarter. Horizon Investments LLC lifted its position in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after buying an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by company insiders.

HCA Healthcare Trading Down 1.0%

HCA Healthcare stock opened at $414.73 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $439.01. The firm has a market capitalization of $97.04 billion, a price-to-earnings ratio of 17.43, a P/E/G ratio of 1.32 and a beta of 1.40. The firm has a 50 day simple moving average of $405.12 and a 200 day simple moving average of $375.58.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s payout ratio is 12.11%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Robert W. Baird lifted their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Bank of America lifted their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Finally, Barclays lifted their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $422.31.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.